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Abstract
In eukaryotes, sphingolipids (SLs) are important membrane components and powerful signaling molecules. In Leishmania,
the major group of SLs is inositol phosphorylceramide (IPC), which is common in yeast and Trypanosomatids but absent in
mammals. In contrast, sphingomyelin is not synthesized by Leishmania but is abundant in mammals. In the promastigote
stage in vitro, Leishmania use SL metabolism as a major pathway to produce ethanolamine (EtN), a metabolite essential for
survival and differentiation from non-virulent procyclics to highly virulent metacyclics. To further probe SL metabolism, we
identified a gene encoding a putative neutral sphingomyelinase (SMase) and/or IPC hydrolase (IPCase), designated ISCL
(Inositol phosphoSphingolipid phospholipase C-Like). Despite the lack of sphingomyelin synthesis, L. major promastigotes
exhibited a potent SMase activity which was abolished upon deletion of ISCL, and increased following over-expression by
episomal complementation. ISCL-dependent activity with sphingomyelin was about 20 fold greater than that seen with IPC.
Null mutants of ISCL (iscl
2) showed modest accumulation of IPC, but grew and differentiated normally in vitro. Interestingly,
iscl
2 mutants did not induce lesion pathology in the susceptible BALB/c mice, yet persisted indefinitely at low levels at the
site of infection. Notably, the acute virulence of iscl
2 was completely restored by the expression of ISCL or heterologous
mammalian or fungal SMases, but not by fungal proteins exhibiting only IPCase activity. Together, these findings strongly
suggest that degradation of host-derived sphingomyelin plays a pivotal role in the proliferation of Leishmania in
mammalian hosts and the manifestation of acute disease pathology.
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Introduction
Leishmania parasites infect 10–12 million people worldwide,
causing a spectrum of diseases known as leishmaniasis [1].
Transmitted by sandflies, these protozoan pathogens have
tremendous negative impacts on public health worldwide,
especially in developing countries [1]. During their life cycle,
Leishmania parasites alternate between flagellate promastigotes
which live in the midgut of sandfly and non-flagellate amastigotes
which reside in the phagosome of mammalian macrophages.
Control of Leishmaniasis has been hampered by the lack of a safe
vaccine, limitation of frontline drugs, and the emergence of drug
resistant strains [2]. To develop new and more cost effective drugs,
it is necessary to understand the molecular mechanism of
Leishmania pathogenesis. A number of surface molecules including
lipophosphoglycan (LPG), glycosylinositolphospholipids (GIPLs),
and the metalloprotease gp63 provide resistance to digestive
enzymes, reactive oxygen species, and complement-mediated lysis
[3,4]. Other virulence factors including the LACK antigen
(Leishmania homologue of receptors for activated C kinase) [5]
and cysteine proteases play important roles in modulating host
immune response [6].
In addition to these well-studied virulence factors, recent work
has provided insight into the function of sphingolipids (SLs) in
Leishmania. SLs are ubiquitous membrane components in eukary-
otes with well-documented functions in general membrane
physiology, raft formation, cell-to-cell recognition, and signaling
[7–10]. Unlike mammalian cells which synthesize sphingomyelin
and glycosylsphingolipids to high abundance, the majority of SLs
in Leishmania are unmodified inositol phosphorylceramide (IPC), a
class of lipids mainly found in fungi and plants [11,12]. The
functions of SLs metabolism in L. major were recently probed using
two deletion mutants: a spt2
2 strain that is SL-free due to the
deletion of an essential subunit gene (SPT2) of serine palmitoyl-
transferase, the first enzyme in the de novo synthesis of SLs (Fig. S1)
[12,13]; and a spl
2 strain that lacks the degradative enzyme
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were fully viable and replicated normally during log phase growth;
however, they died quickly in stationary phase and failed to
differentiate from non-infective procyclics to infective metacyclics
(metacyclogenesis) [14]. Remarkably, supplementation of ethanol-
amine (EtN) or phosphoethanolamine (a product of SPL, Fig. S1)
completely reversed the viability and differentiation defects of both
mutants [14]. EtN is likely used to synthesize plasmenylethano-
lamine (PLE, the dominant phosphatidylethanolamine species in
L. major), a class of plasmalogen lipid that is highly abundant in
metacyclics [12,14]. These results indicate that a main function of
SL synthesis and degradation is to generate EtN, a metabolite
essential for survival and metacyclogenesis in Leishmania promas-
tigotes (Fig. S1). The conversion from SLs to phosphoethanola-
mine could occur via two pathways: an IPC-independent route
directly from sphingoid bases or ceramide, or an alternative route
which requires the synthesis and degradation of IPC (Fig. S1).
Contrary to the problems encountered during metacyclogenesis,
spt2
2 and spl
2 amastigotes (the non-motile forms that reside in
macrophages) were morphologically normal and fully infective
[14]; in addition, expression of SPT2 (mRNAs and protein) was
greatly downregulated in wild type (WT) amastigotes [12]; finally,
amastigotes of WT and spt2
2 contained abundant amounts of IPC
and PLE (similar to WT promastigotes), despite the loss of de novo
SL synthesis and EtN production [15]. Since IPC is not found in
mammals, these results imply: 1) amastigotes acquire SL
metabolites from the mammalian host, either directly or through
the hydrolysis of host SLs to generate metabolite; and 2) salvage of
host lipids may play important roles for the survival and
proliferation of Leishmania amastigotes. To explore the functions
of SL metabolism that are independent of EtN production, it is
necessary to study the enzymes that are directly involved in the
uptake and degradation of host SLs in Leishmania.
In mammalian cells, the sphingomyelinase (SMase)-mediated
sphingomyelin hydrolysis is the major pathway to produce stress-
induced ceramide (Fig. S2) [16]. Ceramide is a well-studied
bioactive molecule implicated in many signaling processes including
apoptosis, inflammation, growth and differentiation [17]. Among
the five known classes of SMases, neutral SMases have emerged as
the main candidates for the production of stress-induced ceramide
[16]. Although yeasts do not synthesize sphingomyelin, they
produce abundant amount of glycosylated inositol phosphocer-
amides (glycosylated IPC) [18,19]. The functional homologue of
mammalian neutral SMase in yeasts is inositol phosphosphingoli-
pid-phospholipase C or IPCase (Fig. S2) [20]. In Saccharomyces
cerevisiae, the activity and localization of IPCase (ScISC1p; encoded
by ScISC1) were regulated in a growth-dependent manner:
predominantly in the endoplasmic reticulum (ER) during early log
stage but associated with mitochondria in late logarithmic growth,
which might lead to the activation of this enzyme by the anionic
phospholipids in the mitochondrial membrane [21,22]. Deletion of
ScISC1 resulted in a slow growth phenotype, suggesting it was
required for the utilization of non-fermentable carbon sources and/
or the respiration function of mitochondria [22]. The null mutant
was also more sensitive to heat and high salt concentration, which
seemed to be linked to the deregulation of several stress-response
genes [23,24]. In the opportunistic fungal pathogen Cryptococcus
neoformans, CnISC1 (which encodes the IPCase in C. neoformans or
CnISC1p) was critical for the survival of this pathogen in
macrophages and its dissemination to the brain [25]. Neither
IPCase nor neutral SMase has been studied in protozoa.
In this report, we identified a single ISCL gene in L. major
homologous to the neutral SMase genes in mammals and the ISC1
genes in fungi (Fig. S3). To study its role in SL metabolism and
pathogenesis, null mutants of ISCL were generated through targeted
gene deletion and results suggest the ability to degrade sphingomy-
elin is essential for acute virulence in Leishmania.
Results
Identification and targeted replacement of ISCL
Through a BLASTp search, ISCL (system ID: LmjF08.0200,
1962 bp) was identified from the L. major genome (www.genedb.org)
as the sole homologue of human neutral SMase 1 (Genbank
accession #NP_003071) and S. cerevisiae ISC1p (Genbank accession
#P40015) (Fig. S3). The predicted protein (ISCL, 653 aa) contains
several conserved amino acids including Glu51, Asp116, Asp383,
and His384 (Fig. S3). From studies of Bacillus cereus SMase [26],
ScISC1p [27], and human neutral SMase 1 [28], these residues may
be critical for Mg
2+ binding, substrate recognition, and catalytic
activity. In addition, ISCL possesses a P-loop motif (His115 to
Lys122) which is found in phosphatases and nucleotide-binding
proteins and may be essential for catalytic efficiency [27]), and two
predicted transmembrane helices near the C-terminus (Ala447 to
Arg466 and Trp612 to Val 634) which may tether the protein to
anionic phospholipid-rich membranes [29] (Fig. S3).
To examine the role of ISCL in SL degradation and virulence, null
mutants were generated in L. major through two rounds of targeted
gene replacement as previously described, since Leishmania are
predominantly diploid [30,31]. Southern-blot analysis confirmed
the loss of both ISCL alleles in two candidate iscl
2 (DISCL::PAC/
DISCL::BSD) clonal lines (Figs. 1A and S4). As a control, these
mutants were complemented with an episome (pXG-ISCL)w h i c h
drove the overexpression of ISCL (Fig. S4). The two clonal lines
showed very similar phenotypes, and thus data for only clone #1-1
and its reconstituted control (iscl
2/+ISCL) are presented here.
Iscl
2 promastigotes were fully viable in log phase but
showed altered morphology and poor viability in late
stationary phase
In culture, iscl
2 promastigotes grew normally with a doubling
time of ,7.0 hours during logarithmic growth phase, indicating
Author Summary
Leishmania are obligate intracellular parasites responsible
for a spectrum of diseases in humans ranging from self-
healing skin lesions to deadly visceral infections. To
survive, they must downregulate the microbicidal activity
and scavenge nutrients from the host. Although Leish-
mania parasites do not synthesize sphingomyelin, which is
an abundant lipid in mammals, they do possess the ability
to hydrolyze sphingomyelin. This neutral sphingomyelin-
ase (SMase) activity is dependent on an ISCL gene, which is
also required for the degradation of inositol phosphor-
ylceramide, the dominant sphingolipid in Leishmania.
Deletion of ISCL in L. major led to a complete loss of
SMase activity but no obvious defects in growth or
differentiation in vitro. Remarkably, null mutants of ISCL
failed to induce any detectable pathology in mammals yet
were able to persist at low levels indefinitely. Such defect
was completely reversed when a functional neutral SMase
was introduced into the mutant. In total, our results
suggest that degradation of host-derived sphingomyelin
by Leishmania is essential for acute virulence. Further
studies will elucidate the pivotal role of sphingolipid
homeostasis in the molecular interaction between Leish-
mania parasites and their mammalian hosts.
Sphingolipid Degradation by Leishmania
PLoS Pathogens | www.plospathogens.org 2 December 2009 | Volume 5 | Issue 12 | e1000692ISCL is not required for survival or replication in the insect stage
(Fig. 1B). The iscl
2 mutants also attained similar densities as WT
parasites in stationary phase (2.5–3.3610
7 cells/ml) (Fig. 1B).
Interestingly, although iscl
2 promastigotes exhibited normal
morphology in log phase and the first 1–2 days in stationary
phase (Fig. 1C–D), they became progressively less elongated in late
stationary phase (Fig. 1C–D). Microscopic evaluations revealed
that after 3 days in stationary phase, 30–40% of iscl
2 cells became
round (round cells were defined as those with the length of the long
axis less than twice the length of the short axis) whereas only 10–
20% of WT cells were round (Fig. 1C–D). This difference became
more pronounced as cultures continued to age, with 70–80% of
round cells in iscl
2 versus 24–38% in WT after 5 days in stationary
phase (Fig. 1C–D). This round phenotype is characteristic of
unhealthy promastigotes, consistent with the increased percentage
of dead cells as 35–49% of iscl
2 became permeable to propidium
iodide versus 10–20% of WT after 3–4 days in stationary phase
(Fig. 1E). These viability and shape defects did not arise from
programmed cell death as iscl
2 parasites showed no characteristics
of apoptosis (such as the exposure of phosphatidylserine or PtS,
data not shown). Importantly, stationary phase defects were solely
due to the loss of ISCL, as the iscl
2/+ISCL and ISCL+/2
(heterozygote) parasites showed normal viability and morphology
(Fig. 1 C–E and data not shown). Finally, these viability and shape
defects could not be reversed by EtN (Fig. 1D–E), which is
different from the stationary phase defects exhibited by spt2
2 and
spl
2 mutants [14].
Iscl
2 mutants showed no apparent defects in
differentiation to metacyclics
For Leishmania promastigotes, the cessation of growth in
stationary phase coincides with the onset of metacyclogenesis,
i.e. differentiation from non-infective procyclic forms to infective
metacyclic forms [32]. Metacyclics can be distinguished from
procyclics based on morphology, reactivity to lectins and
monoclonal antibodies, and density gradient sedimentation
Figure 1. ISCL is not required for growth in promastigotes but plays a crucial role in cell shape and vitality in late stationary phase.
(A) Targeted gene deletion of ISCL. Southern blot analysis of L. major wild type (WT), heterozygote clones (ISCL+/2 #1 and 2), and homozygote
clones (iscl
2 #1-1 and #2-1) was performed as described in Materials and Methods using a probe adjacent to the ISCL locus. Bands corresponding
to the ISCL locus (6.1 Kb) and replacements with drug markers (2.8 Kb for PAC and 2.6 Kb for BSD) are indicated. (B) Iscl
2 mutants had a normal
growth rate. Promastigotes were inoculated in M199 medium at 3.0610
4 cells/ml and culture densities were determined every 8–12 hours using a
hemocytometer. (C)–(E) Iscl
2 mutants showed altered morphology and poor viability in late stationary phase. (C) Representative DIC images of log
and late stationary phase (four days after reaching maximal density) parasites. After entering stationary phase, cells were analyzed daily for
morphology (D, by microscopic observations) and viability (E, by flow cytometry of propidium iodide-positive cells). Experiments were performed in
duplicate or triplicates and error bars represent standard deviations.
doi:10.1371/journal.ppat.1000692.g001
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increased death in stationary phase, it was important to examine
whether the loss of ISCL affected metacyclogenesis. To do so, we
isolated metacyclics from stationary phase iscl
2 parasites after a
Ficoll density gradient centrifugation [34]. These iscl
2 metacyclics
had very similar morphology as those purified from WT and iscl
2/
+ISCL parasites (Fig. 2A). The percentage of iscl
2 metacyclics
increased progressively and peaked at 10–13% after 3–4 days in
stationary phase, as seen with WT and iscl
2/+ISCL parasites
(Fig. 2B). Similar results were observed when metacyclics were
isolated using the peanut agglutination method which is based on
cell surface carbohydrate and antigenic changes between meta-
cyclics and procyclics [33] (data not shown). Together, these data
suggest ISCL is not required for metacyclogenesis, although is
critically involved in the maintenance of cell shape, and, to a lesser
degree, cell viability in late stationary phase.
ISCL is required for the degradation of sphingomyelin
and IPC
Since ISCL is a homolog of mammalian neutral SMase and
fungal ISC1p, we tested whether it is required for the hydrolysis of
sphingomyelin, IPC, or both. Briefly, Leishmania lysates were
incubated with Triton X100/lipid mixed micelles prepared as
described by Okamoto et al. [29] with minor modifications. When
a NBD-labeled C6 sphingomyelin was used as substrate with
whole cell extracts from WT log phase promastigotes, ceramide
(one of the degradative products of SMase) was detected by thin
layer chromatography (TLC) (Fig. 3A–B). This high level of
SMase activity was comparable to what was observed from
mammalian and yeast whole cell lysate [35,36]. In contrast, lysates
from iscl
2 mutants did not induce ceramide production and were
similar to the negative control made of boiled lysate from WT
parasites (Fig. 3A–B), indicating ISCL is required for the hydrolysis
of sphingomyelin in vitro. As expected, the complemented strain
iscl
2/+ISCL, predicted to have increased expression ISCL due to
overexpression from a multicopy episomal vector, exhibited higher
SMase activity (5–7 times more than WT, Fig. 3A–B; Table 1).
Furthermore, we tested whether this ISCL-mediated SMase
activity was sensitive to a specific inhibitor of mammalian neutral
SMase 2, GW4869. As shown in Fig. 3A–B, at a final
concentration of 1 mM, GW4869 completely shut down the
degradation of sphingomyelin in iscl
2/+ISCL, indicating that this
ISCL-dependent Leishmania SMase activity is as sensitive as the
murine neutral SMase 2 (IC50 around 1 mM [37]).
Next, we tested whether ISCL was required for the hydrolysis of
sphingomyelin by intact promastigotes. To do so, parasites were
metabolically labeled with NBD C6 sphingomyelin for 48 hours
and cellular lipids were extracted and analyzed by TLC. As a
control, we added NBD C6 sphingomyelin to growth medium
without parasites for 48 hours and results showed very little
spontaneous degradation (Fig. 3C). Both WT and iscl
2/+ISCL
parasites were capable of sphingomyelin uptake and degradation,
whereas iscl
2 mutants only showed uptake without hydrolysis
(Fig. 3C–D). Therefore, ISCL is essential for the SMase activity in
vivo. Interestingly, iscl
2/+ISCL parasites only caused ,40% more
degradation (based on quantative analysis of the ceramide/
ceramide + sphingomyelin ratio) than WT parasites (Fig. 3C–D).
This differs from the SMase activity data acquired from cell lysate
where iscl
2/+ISCL showed 5–7 times more activity than WT
(Fig. 3A–B).
We next examined whether Leishmania ISCL possessed IPCase
activity. Assays were carried out similarly to those examining
sphingomyelin hydrolysis, but using Triton X100/lipid mixed
micelles containing PtS and NBD-labeled C12 IPC, followed by
lipid extraction and TLC. As shown in Fig. 3E and 3F, WT
parasites exhibited a detectable level of IPCase activity whereas
iscl
2 mutants failed to degrade IPC. Episomal expression of ISCL
in iscl
2/+ISCL led to a marked increase of IPCase activity,
suggesting ISCL is involved in the IPC degradation (Fig. 3E–F).
Notably, the specific activity of IPCase is 10–20 times lower than
that of SMase (Table 1), suggesting sphingomyelin is the preferred
substrate of ISCL.
We then examined the cellular level of IPC, ceramide, and PLE
(which is synthesized from SL-derived EtN) in WT, iscl
2, and
iscl
2/+ISCL promastigotes by electrospray ionization mass spec-
trometry (ESI/MS) in the negative ion mode (Table 2). Abun-
dances of IPC (composed of d16:1/18:0-PI-Cer, d18:1/18:0-PI-
Cer, and d16:1/18:0-PI-PhytoCer [12]) and PLE (composed of
p18:0/18:2-PtE and p18:0/18:1-PtE [12]) were estimated through
comparison with appropriate internal standards (d18:1/8:0-
ceramide phosphate for IPC, d18:1/8:0-ceramide for ceramide,
and p18:0/20:4-PtE for PLE). As summarized in Table 2, iscl
2
mutants contained 53–59% more IPC and 30–52% less ceramide
than WT and iscl
2/+ISC parasites, consistent with a role for ISCL
in IPC degradation. The cellular level of PLE in iscl
2 mutants was
very similar to WT and iscl
2/+ISCL parasites (Table 2). As
described before [12], L. major promastigotes did not contain
sphingomyelin.
Iscl
2 mutants failed to induce pathology in susceptible
mice but persisted for at least 7 months
Next, we assessed the virulence of iscl
2 mutants in BALB/c
mice, which are highly susceptible to L. major. In footpad and
ear infections, WT, ISCL+/2 (heterozygote), and iscl
2/+ISCL
parasites caused rapid progression of lesion which correlated
with the increasing number of parasites in the infected tissue
(Fig. 4A–D and data not shown). Remarkably, neither
stationary phase promastigotes nor purified metacyclics of
iscl
2 mutants induced detectable lesions in the footpads or ears
of BALB/c mice (Fig. 4A–C). This virulence defect was not
reversed by EtN (Fig. 4A), which makes iscl
2 clearly different
from the spt2
2 and spl
2 mutants [14]. The defect in cell
viability was not sufficient to cause a complete loss of virulence
in iscl
2 because we used 3-day old stationary phase promas-
tigotes of which 85–95% of cells were healthy as judged by PI-
Figure 2. Metacyclogenesis is normal in iscl
2 mutants. (A)
Representative DIC images of metacyclics purified from stationary
phase cultures using the density centrifugation method. (B) Percent-
ages of metacyclics were determined daily from low passage (,5)
stationary cultures of WT, iscl
2 (grown in the presence or absence of
200 mM of EtN), and iscl
2/+ISCL) using the density centrifugation
method. Experiments were performed in duplicates and error bars
represent standard deviations.
doi:10.1371/journal.ppat.1000692.g002
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PLoS Pathogens | www.plospathogens.org 4 December 2009 | Volume 5 | Issue 12 | e1000692Figure 3. ISCL is required for the hydrolysis of sphingomyelin and IPC. (A)–(B) In vitro neutral SMase assay. Whole cell lysates from log phase
promastigotes (,40 mg of protein each) were incubated with TX100-based micelles containing NBD-labeled sphingomyelin as described in Materials
andMethods. Neutral SMaseinhibitor GW4869 was providedas indicated (1 mM finalconcentration). Lipids were extracted andseparated by TLC. Plates
were scanned using a Storm 860 phosphoimager and the activity of SMase was normalized to nmol/mg/hour. Positive control (+): 0.1 unit of B. cereus
SMase;negativecontrol(2):boiledWTlysate.(C)–(D)Degradationofsphingomyelinbypromastigotesinvivo.Parasiteswereculturedinthepresenceof
NBD-labeled sphingomyelin for 48 hours and lipids were extracted and separated by TLC (‘‘medium only’’ means NBD-labeled sphingomyelin was
incubatedintheabsenceofparasitesfor48 hours).Ratioofceramide/ceramide+sphingomyelin(SM)wasdeterminedusinganImageAnalysisSoftware
(ImageQuant TL 7.0) and used as an indicator of sphingomyelin hydrolysis. (E)–(F) ISCL is required for the degradation of IPC. Whole cell lysates from log
phase promastigotes (,40 mg of protein each) were incubated with TX100-based micelles containing NBD-labeled IPC as described in Materials and
Methods. Lipids wereextractedandseparatedbyTLC. Plateswere scanned usinga Storm860phosphoimagerandtheactivityofIPCase wasnormalized
to pmol/mg/hour. Experiments were performed in duplicates and error bars represent standard deviations. O:o r i g i no fT L C .
doi:10.1371/journal.ppat.1000692.g003
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iscl
2 that were morphologically normal and impermeable to
propidium iodide also failed to cause pathology (Fig. 3C–D
and data not shown). Despite the lack of pathology, limiting
dilution assays showed iscl
2 mutants were able to persist at the
site of infection at very low levels (50–120 parasites/footpad)
for at least 7 months post infection (Fig. 4D). Therefore, ISCL
was essential for acute virulence and pathology but not long-
term persistence.
To corroborate the results obtained in mouse infections, we
examined the virulence of iscl
2 mutants in an in vitro macrophage
infection assay using peritoneal macrophages isolated from BALB/
c mice [38]. When the infection was performed at 37 uC, iscl
2
mutants were able to bind and enter macrophages efficiently (as
shown by the 2-hour time points in Fig. 4E–F) but these parasites
failed to replicate thereafter and were quickly eliminated (Fig. 4E–
F). In contrast, when the infection was done at 33 uC, iscl
2
mutants were able to survive in macrophages, albeit at a lower
level than WT and iscl
2/+ISCL parasites (2–3 times lower in both
infection rate and the number of parasites/100 macrophages,
Fig. 3G–H). The ability to survive better at lower temperatures
could be related to the ability to survive for long periods in
peripheral mouse tissues like the footpad or ear. Our results also
imply ISCL is involved in heat tolerance as the iscl
2/+ISCL
parasites, which overproduced ISCL from a multicopy episome
(pXG-ISCL), survived better than WT at 37 uC in macrophages
(Fig. 4E–F). The ability to survive better at a lower temperature
could be related to the ability to survive for long periods in
peripheral mouse tissues like the footpad or ear.
Heterologous expression of mammalian neutral SMases
and fungal ISC1ps in iscl
2
To probe the importance of SMase vs. IPCase in Leishmania,w e
expressed SL hydrolases of known specificity in the iscl
2 mutant.
These included human neutral SMase 1 (NP_003071), murine
neutral SMase2 (NM_021491.3), and the S. cerevisiae ISC1p, as this
latter enzyme exhibits both SMase and IPCase activity [39].
Human and murine ORFs were cloned into the pIR1SAT vector
and integrated into the rRNA locus (to generate iscl
2
SSU::hNSM1 or iscl
2 SSU::mNSM2, respectively) which results
in high levels of expression [40]. Similarly, ScISC1 was inserted
into the multicopy episomal vector pXG and transfected into the
iscl
2 mutant yielding iscl
2/+ScISC1, which also yields high level of
expression.
We examined the ability of these transgenic parasites to
hydrolyze sphingomyelin in vivo following provision of NBD C6
sphingomyelin as described above. Both human neutral SMase 1
and murine neutral SMase 2 possessed the ability to break down
sphingomyelin when expressed in iscl
2 promastigotes (Fig. 5A and
5B); in contrast, control parasites transfected with the pIR vector
alone (iscl
2 SSU::pIR) did not exhibit SMase activity despite
maintaining sphingomyelin uptake (Fig. 5A and 5B). Similarly,
expression of ScISC1 restored the ability to degrade sphingomyelin
in iscl
2 (Fig. 5C–D). Consistent with these in vivo labeling results,
we were able to detect strong SMase activity in the in vitro assay
with whole cell lysates from iscl
2 SSU::hNSM1, iscl
2
SSU::mNSM2, and iscl
2/+ScISC1, but not from iscl
2 SSU::pIR
(data not shown). Similar in vitro experiments were performed to
assess whether these SMases could degrade IPC (using NBD C12
IPC as described above) when expressed heterologously in iscl
2
mutants. As shown in Fig. 5E–F, ScISC1 and murine neutral
SMase 2 induced modest IPC degradation, whereas the activity
from human neutral SMase 1 was close to background. Similar to
L. major ISCL, the IPCase activity exhibited by these enzymes were
much lower compared to SMase activity (Table 2).
Complementation of iscl
2 mutants by heterologous
SMases
Next we examined the effects of mammalian neutral SMases
and ScISC1 on cell morphology and virulence in iscl
2. As shown
in Fig. 6A and 6B, both human neutral SMase 1 and murine
neutral SMase 2 reversed the cell shape defects in iscl
2 during
stationary phase and restored the ability to elicit lesion pathology
in BALB/c mice (lesion sizes correlated with parasite numbers in
the footpads, Table S1), whereas control parasites with the empty
vector (iscl
2 SSU::pIR) behaved similarly to the parental iscl
2
mutants. Further analyses confirmed that iscl
2 SSU::hNSM1 and
iscl
2 SSU::mNSM2 also had improved viability in late stationary
phase (by propidium exclusion flow cytometry) and increased
virulence in macrophage infections (data not shown). Therefore,
defects in iscl
2 can be complemented by mammalian neutral
SMases. Similar to mammalian enzymes, ScISC1 completely
restored morphology, viability, and virulence in iscl
2 parasites
(Fig. 6C and 6D), indicating it could functionally substitute ISCL.
Again, lesion pathology induced by iscl
2/+ScISC1 was consistent
with parasite numbers over time (Table S2). Together, our
complementation study strongly suggests that SMase activity is
required for acute virulence in L. major.
Table 1. Summary of neutral SMase and IPCase activity in L. major promastigote lysates.
Activity (pmol/mg/hr) WT iscl
2 iscl
2/+ISCL iscl
2SSU::hNSM1 iscl
2SSU::mNSM2 iscl
2/+ ScISC1 iscl
2/+ CnISC1
SMase 7.9 ,0.1 42 21 100 1.9 0.4
IPCase 0.39 ,0.1 4.4 0.1 0.2 0.3 5.8
Normalized activities of neutral SMase and IPCase (average values) in log phase promastigotes were determined from whole cell extracts (Figs. 3, 5, and data not
shown).
doi:10.1371/journal.ppat.1000692.t001
Table 2. Abundance of IPC, PLE, and ceramide in
promastigotes.
Molecules/cell (610
8)W T iscl
2 iscl
2/+ISCL
IPC 2.52 6 0.52 3.55 6 0.36 2.41 6 0.47
PLE 1.57 6 0.33 1.72 6 0.23 1.47 6 0.42
Ceramide 2.61 6 0.20 1.91 6 0.07 3.41 6 0.47
Abundances of IPC, PLE, and ceramide in stationary phase promastigotes (3
days after reaching maximal density) were determined by quantative mass
spectrometry (with internal standards) as described in Materials and Methods.
Average values from two independent experiments are summarized with
standard deviations.
doi:10.1371/journal.ppat.1000692.t002
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Recently, it was shown by the group of Maurizio Del Poeta
(Medical University of South Carolina, Charleston) that unlike the
ScISC1p, the ISC1 of Cryptococcus neoformans lacked significant
activity with sphingomyelin while retaining activity with IPC (M.
Del Poeta, personal communication). Heterologous expression of
an enzyme lacking SMase activity could thus serve as a probe to
test the relative importance of SMase vs. IPCase activity. The C.neo
ISC1 ORF was inserted into pXG and introduced into the iscl
2
mutant, yielding iscl
2/+CnISC1. Consistent with Del Poeta’s
Figure 4. ISCL is essential for acute virulence but not persistence. (A)–(B) Iscl
2 mutants failed to induce pathology in mice. BALB/c mice were
infected in the footpads (A) or ears (B) with stationary phase promastigotes and lesion sizes were measured weekly with a caliper. (C)–(D) Iscl
2
mutants were able to persist at low levels. BALB/c mice were infected in the footpads with purified metacyclics at 2610
5 parasites per mouse. Lesion
sizes were measured with a caliper (C) and parasite numbers in infected footpads were determined by the limiting dilution assays (D). (E)–(H) Iscl
2
infection of peritoneal macrophages (Mws). Stationary phase promastigotes were used to infect peritoneal Mws from BALB/c mice as described [38].
Percentages of infected Mws( E, G) and the number of parasites per 100 Mws were recorded (F, H). Experiments were performed at 37 uC( E, F)o r
33 uC( G, H). As a control, WT parasites were also used to infect activated Mws( n: stimulated with 100 ng/ml of LPS and 100 ng/ml of IFN-c)t o
ensure these Mws possessed microbicidal activities. Error bars represent standard deviations.
doi:10.1371/journal.ppat.1000692.g004
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but little if any SMase activity (Fig. 5C–F; Table 1).
In contrast to the ability of the SL hydrolases with significant
SMase activity, expression of CnISC1 in iscl
2 did not restore their
ability to induce lesion pathology in susceptible BALB/c mice
infection (Fig. 6C–D). Instead, these iscl
2/+CnISC1 parasites
persisted at low levels in BALB/c mice, similar to those iscl
2
mutants transfected with pIR1SAT vector only (Fig. 6C–D) (Table
S2). Interestingly, the iscl
2/+CnISC1 parasites exhibited normal
morphology (Fig. 6C) and viability (data not shown) in stationary
phase. Therefore, the cell shape defect appears to be separate
from the virulence defect in iscl
2. In total, our complementation
experiments with SL hydrolases suggest the degradation of host
sphingomyelinisessentialforacutepathologyinL.major,whereasthe
activity of IPCase is not required for virulence (Table 1 and Fig. 6).
Expression of surface virulence factors is unaltered in
iscl
2 mutants
Surface glycoconjugates including LPG, GP63, and GIPLs are
important virulence factors in Leishmania. Because the degradation
of IPC generates phosphoinositol (Fig. S2), which could be used to
synthesize GPI-anchored molecules, we tested whether the deletion
of ISCL affects the production of LPG or GP63. Whole cell extracts
from log phase promastigotes were subjected to western-blot
analysis using monoclonal antibody WIC79.3 [41,42] and a rabbit
anti-GP63 antiserum to detect LPG and GP63, respectively. As
illustrated in Fig. 7A, cellular levels of LPG and GP63 were not
significantly altered in iscl
2 mutants or the iscl
2/+ISCL parasites; in
addition, both LPG and GP63 showed normal surface (cell
membrane) localization in log and stationary phases (Fig. 7B and
7C;datanotshown). Together,theseresultsindicate the loss ofISCL
has no adverse effects on the expression or localization of GPI-
anchored molecules. Therefore, the loss of acute virulence in iscl
2 is
not due to defects in surface virulent factors.
Localization of ISCL
To determine the cellular localization of ISCL, a GFP-ISCL
fusion protein was introduced into the iscl
2 mutant. Fluorescence
microscopy revealed the distribution of GFP-ISCL to be similar to
the staining pattern of the mitochondrial marker MitoTracker, in
Figure 5. Heterologous expression of mammalian neutral SMases and fungal ISC1ps in iscl
2. (A)–(B) Iscl
2 parasites with human neutral
SMase 1 (iscl
2 SSU::hNSM1), murine neutral SMase 2 (iscl
2 SSU::mNSM2), or pIR1SAT vector only (iscl
2 SSU::pIR) were labeled with NBD-
sphingomyelin and lipids were examined as described in Fig. 4C. (C)–(D) Similar experiments were performed using iscl
2 parasites transfected with
pIR1SAT-ScISC1 (iscl
2/+ScISC1), pIR1SAT-CnISC1 (iscl
2/+CnISC1), and pIR1SAT vector only (iscl
2/+pIR). To evaluate the degradation of NBD-
sphingomyelin, ratios of ceramide/ceramide + sphingomyelin were determined using an Image Analysis Software (ImageQuant TL 7.0) and shown in
B and D.( E) IPC degradation assay was performed using whole cell lysates from iscl
2 parasites transfected with hNSM1, mNSM2, ScISC1,o rCnISC1;
results were normalized to pmol/mg/hour (F). Positive control (+): 0.1 unit of B. cereus PI-PLC; negative control (2): boiled WT lysate. Experiments
were repeated multiple times and error bars represent standard deviations.
doi:10.1371/journal.ppat.1000692.g005
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2 mutants by mammalian neutral SMases and
fungal ISC1ps. (A)–(B) Morphology and virulence of iscl
2 parasites with human neutral SMase 1 (iscl
2 SSU::hNSM1), murine neutral SMase 2 (iscl
2
SSU::mNSM2), or pIR1SAT vector only (iscl
2 SSU::pIR) were examined as described. (C)–(D) Similar experiments were performed using iscl
2 parasites
transfected with pIR1SAT-ScISC1 (iscl
2/+ScISC1), pIR1SAT-CnISC1 (iscl
2/+CnISC1), and pIR1SAT vector only (iscl
2/+pIR). In (A) and (C), promastigotes
were grown to stationary phase and the percentage of round cells (day 1 through day 5 in stationary phase) was determined. In (B) and (D),
infectivity of stationary phase promastigotes was examined by footpad infection assay using BALB/c mice (2610
7 cells/mouse in B and 1610
6 cells in
D) and the progression of lesions was monitored weekly. Error bars represent standard deviations.
doi:10.1371/journal.ppat.1000692.g006
Figure7.ExpressionofLPGandGP63isnotalterediniscl
2mutants.(A)WholecelllysatesfromlogphasepromastigoteswereresolvedbySDS/
PAGE and blotted to PVDF membranes. Monoclonal antibody WIC79.3 was used to detect LPG; rabbit anti-L. major GP63 polyclonal antibody was used
to detect GP63; and monoclonal anti-a-tubulin antibody (Sigma) was used as a loading control [41]. Localizations of LPG (B; primary antibody: WIC79.3;
secondary antibody: goat anti-mouse IgG-Texas Red) and GP63 (C; primary antibody: a monoclonal anti-L. major GP63 antibody from Cedarlane Inc.;
secondary antibody: goat anti-mouse IgG-FITC) were determined by indirect immuno-fluorescence microscopy as we previously described [12].
doi:10.1371/journal.ppat.1000692.g007
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suggesting this protein is mostly localized in the mitochondria. The
GFP-ISCL was functional, as iscl
2/+GFP-ISCL parasites were able
to degrade sphingomyelin (Fig. 8F) and showed normal morphol-
ogy and virulence (data not shown). GFP-ISCL did not overlap
with the plasma membrane, as revealed using an anti-LPG
monoclonal antibody WIC 79.3 or the endoplasmic reticulum
(ER) revealed by fluorescence microscopy with an anti-T. brucei
Bip antiserum (data not shown).
Next, we examined whether ISCL could be secreted. Promas-
tigotes of iscl
2/+ISCL were grown from log to stationary phase and
culture supernatant was examined for neutral SMase activity. As
shown in Fig. S5, contrary to the robust SMase activity from iscl
2/
+ISCL cells, no activity was detected in the supernatant. Adding
sphingomyelin to the culture medium did not induce any ISCL
secretion (Fig. S5). Similar results were observed with concentrated
supernatant (using filtration-based concentrators) (data not shown).
Therefore, consistent with the localization study and the predicted
ISCL sequence which lacks an obvious signal peptide, promasti-
gotes do not secrete ISCL.
Neutral SMase activity in L. amazonensis amastigotes
The lack of acute virulence in iscl
2 mutants suggests SMase
activity is essential for amastigote survival and replication in the
mammalian host. However, methods for the generation of axenic
L. major parasites amastigotes are not available, and lesion-derived
or macrophage-derived amastigotes typically are contaminated
with host material likely including neutral SMase. To circumvent
this problem, we used L. amazonensis, a new world Leishmania
species able to form axenic amastigotes that resemble closely to
lesion-derived amastigotes in morphology, virulence, expression of
stage-specific genes, and interaction with mammalian cells [43,44].
As shown in Fig. 9, lysates from both promastigotes and
amastigotes of L. amazonensis were able to hydrolyze sphingomy-
elin. Similar to L. major, the neutral SMase activity in L. amazonensis
promastigotes and amastigotes was sensitive to GW4869 (data not
shown). After normalizing to protein levels, a two-fold higher level
of activity was seen in amastigotes than promastigotes (Fig. 9)
(p,0.05). Thus L. amazonensis amastigotes express SMase which
was shown genetically in L. major to be required for parasite
survival and growth in the mammalian host.
Discussion
ISCL is responsible for the degradation of host-derived
sphingomyelin and Leishmania-derived IPC, but is not
required for the production of EtN
In L. major, ISCL is the sole homologue of the neutral SMase
genes in mammals and the ISC1 genes (which encode Inositol
phosphoSphingolipid phospholipase C or IPCase) in fungi (Figs.
S2 and S3). The predicted ISCL contains several well-conserved
regions that are essential for the catalytic activity of SMase and
ISC1p, e.g. a P-loop motif which may be involved in Mg
2+
binding, and two transmembrane helices near the C-terminus,
which may anchor the protein to mitochondrial membrane for
activation [20,27]. Despite the lack of sphingomyelin synthesis, L.
major parasites can actively take up and hydrolyze sphingomyelin
and the neutral SMase activity clearly requires ISCL (Fig. 3A–D).
In addition to sphingomyelin, ISCL also contributes to the
turnover of endogenous IPC as the iscl
2/+ISCL parasites exhibited
elevated IPCase activity whereas the activity in iscl
2 mutants was
close to background (Fig. 3E–F). Consistent with this result, iscl
2
mutants showed modest accumulation of IPC and less ceramide
compared to WT and iscl
2/+ISCL parasites (Table 2). Similar to
mammalian neutral SMases, L. major ISCL exhibited much
stronger activity with sphingomyelin than IPC (10–20 times
higher, Table 1), suggesting sphingomyelin is the preferred
substrate.
For promastigotes, the synthesis and degradation of sphingoid
base is a major pathway to generate EtN [14] (Fig. S1). Although
Leishmania do possess other pathways to generate EtN (such as
salvage from the medium), they are not sufficient to support
growth and metacyclogenesis in the absence of SL metabolism as
manifested by the spt2
2 and spl
2 mutants [14]. As illustrated in
Fig. S1, the production of phosphoethanolamine from SL
metabolites could occur via two routes: an IPC independent route
from sphingoid bases and ceramide; and an alternative route
which requires the synthesis and degradation of IPC (Fig. S1). The
latter is considered a reasonable pathway because SL metabolites
such as sphingoid bases and ceramides are toxic and labile with
low steady state concentrations, whereas IPC is highly abundance
and could serve as a reservoir for EtN production [14]. However,
our results clearly indicate although ISCL is responsible for the
degradation of IPC, it is not essential for EtN production. First,
iscl
2 mutants are fundamentally different from spt2
2 and spl
2
mutants: iscl
2 parasites grow like WT in vitro and form apparently
normal metacyclics yet fail to induce pathology in mice, whereas
spt2
2 and spl
2 mutants grow well but upon entry into stationary
phase die rapidly and fail to differentiate; however, they retain the
ability to yield acute disease pathology, as some surviving parasites
are able to differentiate into amastigotes, which are able to acquire
ethanolamine by savage [14]; second, defects in iscl
2 mutants
cannot be reversed by exogenous EtN at all (Figs. 1–2, 4); third,
the abundance of PLE was similar between iscl
2 mutants and WT
parasites (Table 2). Therefore, there is no shortage of EtN in iscl
2
mutants, suggesting the IPC-independent pathway is sufficient for
EtN/PLE biosynthesis in the absence of ISCL (Fig. S1).
Figure 8. Cellular localization of GFP-tagged ISCL. (A–E) Log
phase WT [pXG-GFP-ISCL] parasites were stained with MitoTracker
Red580 and subjected to fluorescence microscopy. (A) DIC; (B) Hoechst
staining; (C) MitoTracker staining; (D) GFP fluorescence; (E) Merge of C
and D.( F) GFP-ISCL is functional. Whole cell lysates from iscl
2 or iscl
2
transfected with pXG-GFP-ISCL were tested for neutral SMase activity as
described and a representative TLC image is shown. Positive control (+):
0.1 unit of B. cereus SMase; negative control (2): boiled WT lysate.
doi:10.1371/journal.ppat.1000692.g008
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for parasite proliferation and pathology in mammals
The most striking defect of iscl
2 mutants is their complete lack
of acute virulence in susceptible BALB/c mice, as stationary phase
promastigotes or purified metacyclics yielded no pathology even
after 7–8 months (Fig. 4A–D). In vitro macrophage infection
indicated that iscl
2 were able to enter host cells but did not survive
well, especially at 37 uC (Fig. 4E–H). This virulence defect was
completely reversed by the neutral SMases from human, mouse,
and yeast (Table 1) (Fig. 6). We confirmed the finding from Del
Poeta’s group that the C. neo ISC1 lacked significant SMase
activity in our studies, when it was expressed heterologously in
Leishmania (Fig. 5). Despite its strong IPCase activity, heterologous
expression of CnISC1 failed to reverse the virulence defect (Figs. 5–
6). Together, these complementation results strongly suggest the
degradation of host-derived sphingomyelin is necessary and
sufficient for parasite survival and replication in mammals,
whereas the degradation of endogenous IPC by itself is not
essential for Leishmania virulence. In agreement with this
conclusion, axenic amastigotes of L. amazonensis showed strong
SMase activity, about 2-fold higher than promastigotes (Fig. 9).
Interestingly, most GFP-tagged ISCL is localized in the
mitochondria during the promastigote stage (Fig. 8) when cells
can take in sphingomyelin for hydrolysis (Fig. 3E–F). In Leishmania,
lipid vesicles and lipid-protein complexes can be incorporated into
the parasite plasma membrane through fusion or be taken up
through an endocytic pathway including the flagellar pocket and
endosomes [45,46]. Although mitochondria are not directly
connected to the vesicular pathways, phospholipids such as PtS
are synthesized in the ER and transported to the mitochondria
transported in mammalian cells and yeast [47,48]. In S. cerevisiae,
an ER-mitochondria tethering complex has been identified
composed of proteins resident of both ER and mitochondria
[49]. Consistent with these findings, our data imply lipids from the
plasma membrane and/or endocytic compartments may contrib-
ute to the homeostasis of mitochondrial membrane (where GFP-
ISCL resides and the hydrolysis of SLs occurs). Localization of
ISCL in amastigotes is currently under investigation.
In S. cerevisiae, ScISC1p generates phytoceramide in the
mitochondrial membrane and such activity may be important
for the respiratory function of mitochondria and the metabolism of
non-fermentable carbon sources [36]. As promastigotes, Leishmania
acquire energy through the metabolism of sugars, amino acids and
fatty acids [50]. It is possible that the mitochondrion-localized
ISCL has similar functions as the Sc enzyme in regulating
respiration and plays an important role in parasite growth in low
sugar conditions. Consistent with this hypothesis, iscl
2 mutants
showed poor viability and were more round in shape (signs of cells
under stress) in late stationary phase when glucose became
depleted (Fig. 1). Interestingly, although CnISC1p failed to
complement the virulence defect in iscl
2, it did restore the
mutants’ morphology and viability in late stationary phase,
implying that while SMase activity is required for the survival
and proliferation of amastigotes, IPC hydrolysis, however, may be
involved in the maintenance of mitochondrial function in
promastigotes.
In addition to its potential role in mitochondria, we could
envision several other mechanisms by which SMase activity may
contribute to virulence; notably these mechanisms are not
mutually exclusively. First, amastigotes of most Leishmania species
reside within mature phagolysosomes which are enriched in amino
acids and lipids but poor in carbohydrates [51]. To survive, these
amastigotes need to salvage lipids (including SLs) from the host
[15] and SMase (along with other lipases) may be required for the
acquisition of nutrients. In addition, the degradation of host SLs
by amastigotes could disrupt SL-dependent signaling pathways in
macrophages. It has been reported that Leishmania donovani
infection led to elevated ceramide levels in macrophages, which
were responsible for the downregulation of classical PKC activity
and the induction of PKCzeta (an atypical Ca-independent stress
kinase), as well as the ceramide-activated protein phosphatases.
These changes were associated with the inhibition of NF-kappaB
transactivation and the suppression of nitric oxide generation [52–
54]. In the future, molecular interactions between iscl
2 mutants
and host phagocytes will be evaluated to determine whether
sphingomyelin degradation is required for the inhibition of
proinflammatory cytokine release. In addition, the ability of iscl
2
mutants to persist without pathology provides an excellent
platform to study the long-term, asymptomatic infection where
the interaction between Leishmania and host is poorly understood.
Summary
Our study revealed an essential yet previously unrecognized role
of SL degradation in L. major virulence. Despite the lack of
sphingomyelin biosynthesis, Leishmania parasites possess an ISCL-
dependent neutral SMase activity. Deletion of ISCL completely
abolished acute disease pathology in mice. ISCL is also required for
the turnover of IPC, but is not required for the production of EtN.
Future studies will determine the molecular mechanism by which
host-SL degradation contributes to acute virulence.
Figure 9. Detection of neutral SMase activity in L. amazonensis promastigotes and axenic amastigotes. Whole cell lysate from L.
amazonensis promastigotes (pro) and axenic amastigotes (ama) were incubated with NBD-labeled C6 sphingomyelin and neutral SMase activity was
determined by TLC (A) and normalized to nmol/mg/hour (B). Positive control (+): 0.1 unit of B. cereus SMase; negative control (2): boiled L. major WT
lysate. Experiments were repeated multiple times and error bars represent standard deviations. *, p,0.05.
doi:10.1371/journal.ppat.1000692.g009
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Materials
BALB/c (female, 7–8 weeks old) mice were purchased from
Charles River Laboratories International. All procedures involving
mice were approved by the Animal Care and Use Committee at
Texas Tech University (PHS Approved Animal Welfare Assurance
No. A3629-01).
N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-sphin-
gosine-1-phosphocholine (NBD C6-sphingomyelin) was purchased
from Invitrogen Corporation. N-[12-[(7-nitro-2-1,3-benzoxadiazol-
4-yl)amino]dodecanoyl]-sphingosine-1-phosphoinositol (NBD C12-
IPC) was custom-synthesized by Avanti Polar lipids. All other
chemicals were purchased from VWR International unless specified
otherwise.
Molecular constructs
The open reading frame (ORF) of ISCL (LmjF08.0200) was
amplified by PCR from L. major genomic DNA using primer pairs
59ISCL ORF BamHI (attactGGATCCACCATGTCGCACG-
CATCGACCTT, P58) and 39ISCL ORF BamHI (attactG-
GATCCCTACAACTTCTTCAGCT, P59). The resulting DNA
fragment was digested with BamHI and cloned in the pXG vector
[55] as pXG-ISCL (B83) or the pIR1SAT vector [56] as
pIR1SAT-ISCL (B106). After confirming its sequence, ISCL
ORF was cloned into the pXG-GFP+29 vector to generate
pXG-GFP-ISCL (B103), which was used in localization studies. To
generate the knock-out constructs for ISCL, the predicted 59- and
39-untranslated regions (,1 Kb each) were PCR amplified and
cloned in tandem in the pUC18 vector; genes conferring resistance
to puromycin (PAC) and blasticidin (BSD) were inserted between
the 59- and 39-untranslated regions to generate pUC-KO-
ISCL:PAC (B85) and pUC-KO-ISCL:BSD (B84). ORFs of human
neutral SMase 1 (accession #NP_003071) and mouse neutral
SMase 2 (accession #NM_021491.3), derived from constructs
generated in Dr. Yusuf Hannun’s lab (Medical University of South
Carolina), were cloned in the pIR1SAT vector as pIR1SAT-
hNSM1 (B142) and pIR1SAT-mNSM2 (B141), respectively. ISC1
genes from S. cerevisiae (ScISC1, accession #P40015) and C.
neoformans (CnISC1, accession #DQ487762) were PCR amplified
and cloned in the pIR1SAT vector as pIR1SAT-ScISC1 (B108)
and pIR1SAT-CnISC1 (B107), respectively.
Leishmania culture and genetic manipulations
L. major LV39 clone 5 (Rho/SU/59/P) promastigotes were
grown in M199 medium with 10% fetal bovine serum and other
supplements as described [57]. L. amazonensis (MHOM/BR/77/
LTB0016) promastigotes and axenic amastigotes were cultured as
previously described [43,58]. Growth rate was determined by
monitoring the density of culture over time using a hemacytom-
eter. Cell viability was measured by flow cytometry using an
Accuri C6 Flow Cytometer after staining with 5 mg/ml of
propidium iodide. Metacyclics were isolated from stationary phase
culture using the density gradient method [34] and/or the peanut
agglutination method [33]. The ISCL alleles were sequentially
replaced by puromycin (PAC) and blasticidin (BSD) resistance
genes to generate the iscl
2 mutant (DISCL::BSD/DISCL::PAC).
Transfection and selection of promastigotes were performed as
previous described [57]. To confirm the deletion of ISCL, genomic
DNA was digested with NotI plus BamHI, resolved on a 0.8%
agarose gel, transferred to a nitrocellulose membrane, and
hybridized with a [
32P]-labeled DNA probe. To re-constitute
ISCL expression, pXG-ISCL was introduced into iscl
2 and referred
to as iscl
2/+ISCL (DISCL::BSD/DISCL::PAC+ pXG-ISCL). To test
whether iscl
2 can be complemented by mammalian neutral
SMases, linearized DNA (using SwaI) from pIR1SAT-hNSM1
or pIR1SAT-mNSM2 were integrated into the small ribosomal
subunit site of iscl
2 mutants to generate iscl
2 SSU::hNSM1 or
iscl
2 SSU::mNSM2. To test whether iscl
2 can be comple-
mented by fungal ISC1 genes, mutants were transfected with
pIR1SAT-ScISC1 or pIR1SAT-CnISC1 to generate iscl
2/
+ScISC1 or iscl
2/+CnISC1. To study the localization of GFP-
tagged ISCL protein, WT parasites were transfected with
pXG-GFP-ISCL and WT [pXG-GFP-ISCL] cells were selected
based on resistance to G418.
Microscopy and macrophage infection
To analyze the morphology of iscl
2 mutants, log and
stationary phase promastigotes were fixed in 3.7% formalde-
hyde and percentages of round cells (defined as those with the
length of the long axis less than twice the length of the short
axis) were determined using a hemacytometer. About 200
randomly selected cells were counted in each experiment. For
fluorescence microscopy, parasites were stained with 350 nM
of Mitotracker Red 580 (Invitrogen) for 30min in darkness.
Cells were then attached to poly-lysine coated cover slips,
washed twice with phosphate buffered saline (PBS), once with
50% ethanol, and stained with 2.5 mg/ml of Hoechst 33342 for
10min. Images were acquired using an Olympus BX50
Upright Fluorescence Microscope equipped with a digital
camera. Localizations of LPG (primary antibody: WIC79.3
[42]; secondary antibody: goat anti-mouse IgG-Texas Red)
and GP63 (primary antibody: monoclonal anti-L. major GP63
antibody from Cedarlane Inc.; secondary antibody: goat anti-
mouse IgG-FITC) were determined by indirect immuno-
fluorescence microscopy as we previously described [12].
Peritoneal macrophages from BALB/c mice were isolated and
infected with purified stationary phase promastigotes (opsonized
with C57BL6 mouse serum) at a ratio of ten parasites per one
macrophage as previously described [38]. Percentages of infected
macrophages and the number of parasites per 100 macrophages
were determined microscopically after staining with 2.5 mg/ml of
Hoechst 33342.
Mouse infections and analyses
Virulence of promastigotes was evaluated in BALB/c mice
using footpad infection [59] and ear lobe infection [60,61]. For
footpad assay, late stationary phase promastigotes (3 days after
the onset of stationary phase) or purified metacyclics (prepared
from 3–4 days old stationary phase culture) were resuspended
in DMEM and injected into the footpads of 8-week old female
BALB/c mice (6–10 mice per group) at 1610
6 cells/mouse
(stationary phase promastigotes) or 2610
5 cells/mouse (meta-
cyclics). For ear lobe infection, stationary phase parasites were
inoculated intradermally into the ear lobes of 8-week old
female BALB/c mice (5 mice per group) at 1610
5 cells/mouse.
Lesion sizes were measured weekly using a vernier caliper and
parasite numbers in the infected tissue were determined by
limiting dilution assay [59]. Mice infected with WT or iscl
2/
+ISCL parasites were sacrificed when their lesions became
overly large (over 2.5 mm for footpad infection and over
5.0 mm for ear infection).
Neutral SMase assay and IPCase assay
Log phase promastigotes were suspended in a lysis buffer
(25mM Tris pH7.5, 0.1% Triton X100, 16protease inhibitor) at
2.0610
8 cells/ml and incubated for 5 min on ice. Protein
concentration was determined by the micro-BCA assay. Triton
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[29] with minor modifications. For neutral SMase assay, 40 mgo f
Leishmania protein (,20 ml of lysate) was incubated in 100 mlo f
buffer containing 50mM Tris pH7.5, 5mM MgCl2, 5mM
dithiothreitol, 0.1% Triton X100, 11 nmol of PtS (Avanti),
2.8 nmol of unlabeled sphingomyelin (Avanti), and 0.8 nmol of
NBD C6-sphingomyelin. After incubation at room temperature
for 60 min, 1 ml of chloroform, 0.5 ml of methanol, and 0.2 ml of
water were added to each reaction and lipid was extracted, dried,
and resuspended in 20 ml of chloroform: methanol (1:2). Thin
layer chromatography (TLC) was performed as we previously
described [12] and plates were scanned with a Storm 860
phosphoimager. Results were normalized to nmol/mg/hour after
subtracting the value of negative control. 0.1 unit of Bacillus cereus
SMase (Sigma) was used as a positive control and boiled WT lysate
(40 mg) was used as a negative control. For IPCase assay, similar
experiments were performed except: 1) lysate was incubated in the
absence of sphingomyelin and presence of 0.8 nmol of NBD C12-
IPC; 2) TLC plates were developed in a different solvent
(chloroform:methanol:water=65:24:5); and 3) 0.1 unit of Bacillus
cereus phosphatidylinositol phospholipase C (PI-PLC, Sigma) was
used as a positive control.
Degradation of sphingomyelin by intact L. major
promastigotes
Promastigotes were inoculated in M199 medium without fetal
bovine serum at 7.0610
5 cells/ml and labeled with 5 mM of NBD
C6-sphingomyelin. After 48 h, cells were washed with PBS and
total lipids were extracted and analyzed by TLC as described
above for neutral SMase assay.
Lipid analysis by electrospray ionization mass
spectrometry
Lipid extraction and analysis by ESI/MS (negative ion mode)
was performed as previously described [15] with minor modifica-
tions. A N-octanoyl-D-erythro-sphingosine-1-phosphate (d18:1/8:0
ceramide phosphate, FW=505.5, 1.0610
8 molecules/cell) was
used as a standard for IPC; a 1-O-19-(Z)-octadecenyl-2-arachidoyl-
sn-glycero-3-phosphoethanolamine (p18:0/20:4-PE, FW=751.6,
2.0610
8 molecules/cell) was used as a standard for PLE; and a N-
octanoyl-D-erythro-sphingosine (d18:1/8:0 ceramide, FW=425.7,
1.0610
8 molecules/cell) was used as a standard for ceramide. All
three internal standards were added prior to lipid extraction.
Western-blot of LPG and GP63
Promastigotes were collected and resuspended in PBS at
1610
8cells/ml. Cell extracts were prepared and western-blotting
were performed as previously described [12]. Primary antibodies
include the rabbit anti-GP63 polyclonal antiserum (a generous gift
from Dr. KP Chang at Rosalind Franklin University of Medicine
and Science) (1:10000), monoclonal anti-L. major LPG antibody
WIC79.3 [42] (1:5000), and monoclonal anti-a-tubulin antibody
(Sigma) (1:8000); secondary antibodies include the goat anti-rabbit
or anti-mouse IgG Ab–HRP conjugated (1:2000).
Supporting Information
Figure S1 Metabolism of SLs in L. major. SPT: serine
palmitoyltransferase; SPL: sphingosine- 1-phosphate lyase; ISC1p:
inositol phosphosphingolipid phospholipase C 1 protein or
IPCase; IPCS: IPC synthase. Note that phosphoethanolamine
can be produced via an IPC-independent pathway or an indirect
pathway that requires the synthesis and degradation of IPC.
Found at: doi:10.1371/journal.ppat.1000692.s001 (0.07 MB PDF)
Figure S2 Degradation of sphingomyelin (A) and IPC (B). In
mammals, the degradation of sphingomyelin by SMase is a major
route to produce ceramide, an important signaling molecule.
Leishmania parasites do not synthesize sphingomyelin but contain
high abundance of IPC. In fungi (which also synthesize IPC),
hydrolysis of IPC is mediated by inositol phosphosphingolipid
phospholipase C (ISC1p, B), a homolog of mammalian neutral
SMase.
Found at: doi:10.1371/journal.ppat.1000692.s002 (0.11 MB PDF)
Figure S3 Alignment of the amino acid sequences of LmISCLp
(L. major geneDB system ID LmjF08.0200), human neutral SMase
1 (Genbank accession #NP_003071), and Saccharomyces cerevisiae
ISC1p (Genbank accession #P40015). Highly conserved regions
are shaded. The P-loop domain is underlined. The two boxed
regions near the C-terminus of LmISCLp (at aa 447–466 and 612–
634) represent predicted transmembrane helices. Asterisks repre-
sent amino acids essential for catalysis based on studies of B. cereus
SMase [26], ScISC1p [27], and HsNSMase 1 [28].
Found at: doi:10.1371/journal.ppat.1000692.s003 (0.11 MB PDF)
Figure S4 Targeted deletion of ISCL. Southern blot analysis of
L. major wild type (WT), heterozygote clones (ISCL+/2 #1 and 2),
homozygote clones (iscl
2 #1-1 and #2-1), and the reconstituted
strain (iscl
2/+ISCL) was performed as described in Materials and
Methods using a probe corresponding to the ISCL ORF. Bands
corresponding to the endogenous (.10 Kb, 24 hours exposure)
and episomal alleles of ISCL (,2.0 Kb, 3 hours exposure) are
indicated.
Found at: doi:10.1371/journal.ppat.1000692.s004 (0.05 MB PDF)
Figure S5 L. major promastigotes do not secrete ISCL protein.
Promastigotes of iscl
2/+ISCL were grown in the absence or
presence of C16-sphingomyelin (provided at 1 mM final concen-
tration daily) and neutral SMase assay was performed using whole
cell lysate or culture supernatant. Positive control (+): 0.1 unit of B.
cereus SMase; negative control (2): boiled WT lysate.
Found at: doi:10.1371/journal.ppat.1000692.s005 (0.06 MB PDF)
Table S1 Parasite number in BALB/c mice infected with
iscl
2SSU::hNSM1, iscl
2SSU::mNSM2, and iscl
2SSU::pIR (as de-
scribed in Fig. 6B). Limiting dilution assays were performed at 4–5
weeks post infection (two mice per group).
Found at: doi:10.1371/journal.ppat.1000692.s006 (0.01 MB PDF)
Table S2 Parasite numbers in BALB/c mice infected with L.
major promastigote (as described in Fig. 6D). Limiting dilution
assays were performed at 6–7 weeks post infection (two mice per
group).
Found at: doi:10.1371/journal.ppat.1000692.s007 (0.01 MB PDF)
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